A recent EPO Board of Appeal decision confirms that applicants can correct errors in grant texts through appeal, but may still have to pay the appeal fee if they failed to identify the mistake earlier.
A recent EPO appeal decision highlights the risks of claim alternatives, confirming that each alternative must independently meet sufficiency requirements.
Learn how chemistry start-ups can avoid 10 common patent portfolio mistakes and build an IP strategy that protects innovation, attracts investors and supports long-term commercial success.
Explore how major biotech and pharmaceutical jurisdictions approach double patenting and divisional applications, and discover strategies for building stronger global patent portfolios.
A recent UPC decision highlights the risks of delaying an opt out. Learn why early action may be essential to keep European patents outside UPC jurisdiction.
EPO patent filings show strong growth in materials, food technology, coatings and surface technologies, highlighting innovation driven by sustainability and advanced manufacturing.
Discover the key patent portfolio questions investors ask during IP due diligence and how chemistry and materials companies can strengthen investor confidence and support fundraising success.
New UK IPO guidance following the Emotional Perception AI ruling brings greater clarity to patent examination, aligning UK practice with the EPO and impacting AI, software and quantum computing inventions.
Discover how Tyruko compares with Tysabri, including biosimilar approval, manufacturing and formulation differences, patent considerations and the investigation into reported adverse patient outcomes.
Eminem has suffered a setback in his Australian dispute with Swim Shady. The ruling highlights why trade mark owners must file strategically and retain evidence of genuine use.
